A1 Refereed original research article in a scientific journal

Prevalence, risk factors and mortality associated with colonic atresia: a population-based case-control study




AuthorsKankaristo, Roni; Helenius, Ilkka; Heiskanen, Susanna; Syvänen, Johanna; Kemppainen, Teemu; Löyttyniemi, Eliisa; Gissler, Mika; Raitio, Arimatias

Publication year2026

Journal: Pediatric Surgery International

Article number51

Volume42

Issue1

ISSN0179-0358

eISSN1437-9813

DOIhttps://doi.org/10.1007/s00383-025-06284-4

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://link.springer.com/article/10.1007/s00383-025-06284-4

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/506452428


Abstract

Purpose: This study aims to explore maternal and pregnancy-related risk factors for colonic atresia (CA) and assess the national total prevalence, mortality, and frequency of co-occurring anomalies of this rare malformation in 2004-2017.

Methods: This case-control study involved 36 cases with congenital CA identified from several Finnish registers. All cases were identified based on the ICD-9/ICD-10 codes and classified based on co-occurring anomalies. Five controls without gastrointestinal congenital malformations matched for residence and time of conception (± 1 year) were randomly selected for each case. Maternal risk factors were analyzed with data from the same registers.

Results: Total prevalence of CA was 0.45/10,000, birth prevalence was 0.37/10,000 and live birth prevalence was 0.36/10,000. The overall prevalence trend did not change (p = 0.11) during the study period. There were 15 (41.7%) isolated cases, 3 (8.3%) were associated with known syndromes and 18 (50.0%) had multiple congenital anomalies. Together there were 19.4% (n = 7) terminations or neonatal mortalities. An association was observed with maternal diabetes and CA (p = 0.03).

Conclusion: The prevalence of CA in Finland is low with no significant change over the study period. Despite the high frequency of associated anomalies, the overall survival of CA is very high, 97%.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
Open Access funding provided by University of Turku (including Turku University Central Hospital). Dr Raitio reports grants from the Finnish Paediatric Research Foundation and Päivikki and Sakari Sohlberg Foundation and Dr. Helenius from Finnish State Funding via Helsinki and Turku University Hospitals.


Last updated on 05/01/2026 02:40:11 PM